Department of Diagnostic Radiology, The University of Texas M.D. Anderson Cancer Center, Houston, TX.
Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX.
Spine (Phila Pa 1976). 2017 May 15;42(10):E629-E632. doi: 10.1097/BRS.0000000000001951.
Case report and literature review.
To describe treatment of a unique case of acute airway obstruction by a large C7 giant cell tumor (GCT) with preoperative denosumab followed by surgical resection, and review the literature on this rare entity.
Standard treatment for GCTs includes surgical resection or curettage and packing. Large lesions in the spine may require preoperative therapy with denosumab, a human monoclonal antibody to RANKL, to facilitate surgery. It is highly unusual for GCT arising in cervical spine to present with acute asphyxia (requiring tracheostomy).
We report a patient with large C7 GCT that caused tracheal compression with almost complete airway obstruction requiring emergency intubation.
The tumor responded to subcutaneously administered denosumab with marked decrease in size and relief of symptoms. Increased tumor mineralization in response to therapy facilitated subsequent successful surgical tumor resection. The patient remains symptom-free 2 years after surgery without tumor recurrence.
Denosumab can shrink the size of large GCTs, providing symptom relief before surgery and facilitate tumor resection.
病例报告和文献回顾。
描述一例 C7 巨大细胞瘤(GCT)引起的急性气道阻塞的独特治疗方法,该患者在术前接受地舒单抗治疗,然后进行手术切除,并对这一罕见实体瘤的文献进行回顾。
GCT 的标准治疗包括手术切除或刮除和填塞。脊柱内的大病变可能需要术前用地舒单抗(一种针对 RANKL 的人源单克隆抗体)进行治疗,以促进手术。颈椎 GCT 引起急性窒息(需要气管切开术)极为罕见。
我们报告了一例 C7 巨大细胞瘤患者,该肿瘤压迫气管,导致几乎完全气道阻塞,需要紧急插管。
肿瘤对皮下给予的地舒单抗有反应,体积明显缩小,症状缓解。治疗引起的肿瘤矿化增加,随后成功进行了手术肿瘤切除。患者在手术后 2 年无肿瘤复发,且无任何症状。
地舒单抗可缩小大型 GCT 的体积,在手术前缓解症状,并有助于肿瘤切除。
5 级。